Akeylink
Latest round
- Series A
Last raised
- Oct 2025
Total raised
- Undisclosed
Investors
- 1
About Akeylink
, trading as Akeylink, focuses on the research and development of innovative drugs in the fields of antiviral and liver diseases. The company specializes in developing innovative software solutions designed to streamline business operations and enhance productivity across various industries. The company's flagship product is a comprehensive enterprise resource planning (ERP) system that integrates key business functions such as inventory management, financial reporting, and customer relationship management into a single platform. This system allows businesses to automate processes, improve data accuracy, and foster collaboration among departments. The company’s client base includes small to medium-sized enterprises in sectors such as manufacturing, retail, and logistics, primarily serving markets in North America, Europe, and parts of Asia. The company generates revenue through a subscription-based model, where clients pay for access to its software solutions on a monthly or annual basis.
Who invested in Akeylink
1 investor across 1 round
See all investors in Akeylink
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 16, 2025
Amount
Undisclosed
Investors
Questions about Akeylink
Who invested in Akeylink?
Akeylink has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Akeylink raised?
Akeylink has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Akeylink last raise money?
Akeylink's most recent round on record is a Series A, in Oct 2025.
What does Akeylink do?
, trading as Akeylink, focuses on the research and development of innovative drugs in the fields of antiviral and liver diseases.
Where is Akeylink headquartered?
Akeylink is headquartered in Shanghai, China.
Which VCs invest in companies like Akeylink?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Akeylink's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Akeylink? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.